The Added Value of CT Angiography Prior To Transarterial Chemoembolization of Hepatocellular Carcinoma
Darweesh, R., Enekidy, A., Aassar, O., Mahmoud AbdelRahman, N. (2024). The Added Value of CT Angiography Prior To Transarterial Chemoembolization of Hepatocellular Carcinoma. EKB Journal Management System, 6(4), 32-33. doi: 10.21608/alexpo.2024.328246.1970
Reda Darweesh; Abdelaziz Mohammed Enekidy; Omar Aassar; Nour AbdelRahman Mahmoud AbdelRahman. "The Added Value of CT Angiography Prior To Transarterial Chemoembolization of Hepatocellular Carcinoma". EKB Journal Management System, 6, 4, 2024, 32-33. doi: 10.21608/alexpo.2024.328246.1970
Darweesh, R., Enekidy, A., Aassar, O., Mahmoud AbdelRahman, N. (2024). 'The Added Value of CT Angiography Prior To Transarterial Chemoembolization of Hepatocellular Carcinoma', EKB Journal Management System, 6(4), pp. 32-33. doi: 10.21608/alexpo.2024.328246.1970
Darweesh, R., Enekidy, A., Aassar, O., Mahmoud AbdelRahman, N. The Added Value of CT Angiography Prior To Transarterial Chemoembolization of Hepatocellular Carcinoma. EKB Journal Management System, 2024; 6(4): 32-33. doi: 10.21608/alexpo.2024.328246.1970

The Added Value of CT Angiography Prior To Transarterial Chemoembolization of Hepatocellular Carcinoma

ALEXMED ePosters
Article 1, Volume 6, Issue 4, September 2024, Pages 32-33
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2024.328246.1970
Authors
Reda Darweesh1; Abdelaziz Mohammed Enekidy2; Omar Aassar3; Nour AbdelRahman Mahmoud AbdelRahman* 1
1Department of Radiodiagnosis and Intervention, Faculty of Medicine, Alexandria University
2Faculty of medicine alexandria unversity radiology departement
3Lecturer in Radiodiagnosis, Faculty of Medicine, University of Alexandria,
Abstract
Introduction:
Hepatocellular carcinoma (HCC) accounts for 85–90% of primary liver cancers. Globally, it is the fifth most common cancer in men and the seventh in women.
Radiofrequency ablation (RFA), liver resection, and liver transplantation are the only curative options for patients with early-stage hepatocellular carcinoma (HCC). For those with intermediate-stage HCC (BCLC group B) who are not candidates for resection or ablation, trans-arterial chemoembolization (TACE) serves as the standard palliative treatment. In recent years, TACE has also emerged as a feasible treatment for certain advanced-stage HCC patients (BCLC group C).
To successfully perform trans-arterial chemoembolization (TACE), interventional radiologists must accurately map the feeding arteries of hepatocellular carcinoma (HCC), including hepatic artery variations and accessory or parasitic peri-hepatic arteries. Without proper mapping, the procedure can be technically difficult and incomplete. Extrahepatic collateral arteries supplying HCC are present in 17% to 27% of cases. Multidetector computed tomography angiography (MDCTA), a noninvasive technique, is used to visualize hepatic and perihepatic vessels and identify tumor-feeding arteries before TACE.
Keywords
Angiography; Transarterial Chemoembolization; HCC
Supplementary Files
Statistics
Article View: 4